Abstract
We report the development of a new method to induce glioblastoma multiforme in adult immunocompetent mice by injecting Cre-loxP–controlled lentiviral vectors expressing oncogenes. Cell type- or region-specific expression of activated forms of the oncoproteins Harvey-Ras and AKT in fewer than 60 glial fibrillary acidic protein–positive cells in the hippocampus, subventricular zone or cortex of mice heterozygous for the gene encoding the tumor suppressor Tp53 were tested. Mice developed glioblastoma multiforme when transduced either in the subventricular zone or the hippocampus. However, tumors were rarely detected when the mice were transduced in the cortex. Transplantation of brain tumor cells into naive recipient mouse brain resulted in the formation of glioblastoma multiforme–like tumors, which contained CD133+ cells, formed tumorspheres and could differentiate into neurons and astrocytes. We suggest that the use of Cre-loxP–controlled lentiviral vectors is a novel way to generate a mouse glioblastoma multiforme model in a region- and cell type-specific manner in adult mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hesselager, G. & Holland, E.C. Using mice to decipher the molecular genetics of brain tumors. Neurosurgery 53, 685–694; discussion 695 (2003).
Holland, E.C. Glioblastoma multiforme: the terminator. Proc. Natl. Acad. Sci. USA 97, 6242–6244 (2000).
Holland, E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2, 120–129 (2001).
Vescovi, A.L., Galli, R. & Reynolds, B.A. Brain tumour stem cells. Nat. Rev. Cancer 6, 425–436 (2006).
Kafri, T., Blomer, U., Peterson, D.A., Gage, F.H. & Verma, I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314–317 (1997).
Abremski, K., Hoess, R. & Sternberg, N. Studies on the properties of P1 site-specific recombination: evidence for topologically unlinked products following recombination. Cell 32, 1301–1311 (1983).
Guha, A., Feldkamp, M.M., Lau, N., Boss, G. & Pawson, A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15, 2755–2765 (1997).
Doetsch, F., Caille, I., Lim, D.A. & Garcia-Verdugo, J.M. & Alvarez-Buylla, A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97, 703–716 (1999).
Zhuo, L. et al. hGFAP-Cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85–94 (2001).
Malatesta, P. et al. Neuronal or glial progeny: regional differences in radial glia fate. Neuron 37, 751–764 (2003).
Holland, E.C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25, 55–57 (2000).
Steck, P.A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356–362 (1997).
Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
Ekstrand, A.J. et al. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9, 2313–2320 (1994).
Maher, E.A. et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311–1333 (2001).
Lang, F.F., Miller, D.C., Koslow, M. & Newcomb, E.W. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J. Neurosurg. 81, 427–436 (1994).
Watanabe, K. et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6, 217–223; discussion 223–214 (1996).
Dahlstrand, J., Collins, V.P. & Lendahl, U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res. 52, 5334–5341 (1992).
Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660 (2007).
Barak, Y., Juven, T., Haffner, R. & Oren, M. Mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461–468 (1993).
Reynolds, B.A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707–1710 (1992).
Houchens, D.P., Ovejera, A.A., Riblet, S.M. & Slagel, D.E. Human brain tumor xenografts in nude mice as a chemotherapy model. Eur. J. Cancer Clin. Oncol. 19, 799–805 (1983).
Hu, B. et al. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc. Natl. Acad. Sci. USA 100, 8904–8909 (2003).
Singh, S.K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
Finkelstein, S.D. et al. Histological characteristics and expression of acidic and basic fibroblast growth factor genes in intracerebral xenogeneic transplants of human glioma cells. Neurosurgery 34, 136–143 (1994).
Uhrbom, L., Hesselager, G., Nister, M. & Westermark, B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 58, 5275–5279 (1998).
Holland, E.C. & Varmus, H.E. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc. Natl. Acad. Sci. USA 95, 1218–1223 (1998).
Garcia, A.D., Doan, N.B., Imura, T., Bush, T.G. & Sofroniew, M.V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233–1241 (2004).
Lantos, P.L. & Cox, D.J. The origin of experimental brain tumours: a sequential study. Experientia 32, 1467–1468 (1976).
Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463–8471 (1998).
Ikawa, M., Tanaka, N., Kao, W.W. & Verma, I.M. Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol. Ther. 8, 666–673 (2003).
Ray, J. & Gage, F.H. Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Mol. Cell. Neurosci. 31, 560–573 (2006).
Marumoto, T. et al. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J. Biol. Chem. 278, 51786–51795 (2003).
Gage, F.H. et al. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. USA 92, 11879–11883 (1995).
Gagneux, P. et al. Human-specific regulation of α 2–6-linked sialic acids. J. Biol. Chem. 278, 48245–48250 (2003).
Acknowledgements
We thank R. Shaw for discussions and critical reading of the manuscript; N. Varki and H. Powell for pathological analyses; S. Ylä-Herttuala, K. Suzuki, N. Tanaka, G. Pao, A. Parker and H. Suh for useful discussions; T. Sawai, G. Estepa and M. Lawrence for technical assistance; M. Schmitt and B. Coyne for administrative assistance; and S. Withoff (St. Jude Hospital), V. Tergaonkar (Bioprocessing Technology Institute), O. Singer (Salk Institute) and G. Wahl (Salk Institute) for providing pSETB mRFP1, pGEM H-RasV12, p156RRLsin PPTCMVIRESPRE myr-AKT vectors and Tp53−/− mice, respectively. T.M. is supported by the American Brain Tumor Association. I.M.V. is an American Cancer Society Professor of Molecular Biology and is supported in part by grants from the US National Institutes of Health and the H.N. and Frances C. Berger Foundation. The project described was supported in part by the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
T.M. conducted most of the experiments, prepared figures and wrote the manuscript. A.T., D.F.-M. and Y.S. participated in in vivo studies and histological analysis. M.S. performed MRI imaging. F.H.G. supervised the experiments and the project. I.M.V. is the principle investigator, supervised the experiments and the project and wrote the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1–8 and Supplementary Tables 1–3 (PDF 1522 kb)
Rights and permissions
About this article
Cite this article
Marumoto, T., Tashiro, A., Friedmann-Morvinski, D. et al. Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15, 110–116 (2009). https://doi.org/10.1038/nm.1863
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.1863
This article is cited by
-
Understanding current experimental models of glioblastoma-brain microenvironment interactions
Journal of Neuro-Oncology (2024)
-
Immunotherapy for glioblastoma: the promise of combination strategies
Journal of Experimental & Clinical Cancer Research (2022)
-
Functional virus-specific memory T cells survey glioblastoma
Cancer Immunology, Immunotherapy (2022)
-
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
Nature Communications (2021)
-
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
Nature Communications (2021)